GEP19971025B - Process for producing lyophilizate - Google Patents
Process for producing lyophilizateInfo
- Publication number
- GEP19971025B GEP19971025B GEAP1993972A GEAP1993000972A GEP19971025B GE P19971025 B GEP19971025 B GE P19971025B GE AP1993972 A GEAP1993972 A GE AP1993972A GE AP1993000972 A GEAP1993000972 A GE AP1993000972A GE P19971025 B GEP19971025 B GE P19971025B
- Authority
- GE
- Georgia
- Prior art keywords
- lyophilizate
- water
- producing
- iphosphamide
- refrigerated
- Prior art date
Links
- HOMGKSMUEGBAAB-UHFFFAOYSA-N ifosfamide Chemical compound ClCCNP1(=O)OCCCN1CCCl HOMGKSMUEGBAAB-UHFFFAOYSA-N 0.000 abstract 3
- 229960001101 ifosfamide Drugs 0.000 abstract 3
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 2
- ACGUYXCXAPNIKK-UHFFFAOYSA-N hexachlorophene Chemical compound OC1=C(Cl)C=C(Cl)C(Cl)=C1CC1=C(O)C(Cl)=CC(Cl)=C1Cl ACGUYXCXAPNIKK-UHFFFAOYSA-N 0.000 abstract 1
- FBPFZTCFMRRESA-UHFFFAOYSA-N hexane-1,2,3,4,5,6-hexol Chemical compound OCC(O)C(O)C(O)C(O)CO FBPFZTCFMRRESA-UHFFFAOYSA-N 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Cephalosporin Compounds (AREA)
- Amplifiers (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Indole Compounds (AREA)
- Control Of El Displays (AREA)
- Diaphragms For Electromechanical Transducers (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE3637089 | 1986-10-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GEP19971025B true GEP19971025B (en) | 1997-04-06 |
Family
ID=6312873
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GEAP1993972A GEP19971025B (en) | 1986-10-31 | 1993-07-07 | Process for producing lyophilizate |
Country Status (25)
| Country | Link |
|---|---|
| EP (1) | EP0265812B1 (enExample) |
| JP (1) | JPS63159319A (enExample) |
| KR (1) | KR900003491B1 (enExample) |
| AT (1) | ATE55250T1 (enExample) |
| AU (1) | AU598602B2 (enExample) |
| CA (1) | CA1314231C (enExample) |
| DD (1) | DD262582A5 (enExample) |
| DE (1) | DE3764235D1 (enExample) |
| DK (1) | DK169308B1 (enExample) |
| EG (1) | EG18333A (enExample) |
| ES (1) | ES2017982B3 (enExample) |
| FI (1) | FI87140C (enExample) |
| GE (1) | GEP19971025B (enExample) |
| GR (1) | GR3000708T3 (enExample) |
| HU (1) | HU197987B (enExample) |
| IL (1) | IL84312A (enExample) |
| IN (1) | IN168119B (enExample) |
| LV (1) | LV10051B (enExample) |
| MX (1) | MX8958A (enExample) |
| NO (1) | NO873860L (enExample) |
| PT (1) | PT86032B (enExample) |
| RU (1) | RU1836079C (enExample) |
| UA (1) | UA11075A (enExample) |
| YU (1) | YU197387A (enExample) |
| ZA (1) | ZA878183B (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0334083B1 (de) * | 1988-03-19 | 1991-07-24 | ASTA Pharma Aktiengesellschaft | Ifosfamid-Mesna-Lyophilisat und Verfahren zu dessen Herstellung |
| US5227373A (en) * | 1991-10-23 | 1993-07-13 | Bristol-Myers Squibb Co. | Lyophilized ifosfamide compositions |
| WO1995007083A1 (en) * | 1993-09-10 | 1995-03-16 | F.H. Faulding & Co. Limited | Ifosfamide lyophilisate composition |
| DE19529057B4 (de) * | 1995-08-08 | 2007-12-13 | Baxter Healthcare S.A. | Ifosfamid-Lyophilisat-Zubereitungen |
| DE69928500T2 (de) * | 1998-03-03 | 2006-08-03 | Eli Lilly And Co., Indianapolis | Pharmazeutische zusammensetzung enthaltend den phospholipase inhibitor natrium-[[3-(2-amino-1,2-dioxoethyl)-2-ethyl-1-phenylmethyl)-1 h-indol-4-yl]oxy]acetat |
| CA2497898C (en) * | 2002-09-05 | 2012-02-07 | Bharat Serums & Vaccines Ltd. | Liquid stable composition of oxazaphosphorine with mesna |
| CN100463678C (zh) * | 2002-12-02 | 2009-02-25 | 印度血清及疫苗有限公司 | 用于肠胃外给药的异环磷酰胺组合物及其制备方法 |
| US8436190B2 (en) * | 2005-01-14 | 2013-05-07 | Cephalon, Inc. | Bendamustine pharmaceutical compositions |
| BRPI0715279A2 (pt) * | 2006-09-29 | 2013-06-11 | Infa Sa | sistema de embalagem, sistema de embalagem para uma composiÇço farmacÊutica, mÉtodo para transferir uma composiÇço farmcÊutica para administraÇço por infusço intravenosa, uso de um sistema de embalagem, kit para administraÇço parenteral de fÁrmacos com um acesso intravenoso e kit admnistraÇço parenteral de princÍpios ativos |
| CN105900385B (zh) * | 2014-12-04 | 2019-08-27 | 华为技术有限公司 | 在数据通信网中的负载分配 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3732340A (en) * | 1966-07-11 | 1973-05-08 | Asta Werke Ag Chem Fab | N',o-propylene phosphoric acid ester diamides |
| DE2750207A1 (de) * | 1977-05-09 | 1978-11-16 | Walton J Smith | Gefriergetrocknete zusammensetzungen, insbesondere gefriergetrocknete pharmazeutische praeparate und verfahren zu deren herstellung |
| DE3279834D1 (en) * | 1981-12-31 | 1989-08-31 | Asta Pharma Ag | 4-sulfido-oxaza phosphorines and their use in the treatment of cancer, and in immunosuppression |
| US4537883A (en) * | 1982-11-12 | 1985-08-27 | Mead Johnson & Company | Lyophilized cyclophosphamide |
-
1987
- 1987-09-15 NO NO873860A patent/NO873860L/no unknown
- 1987-10-20 ES ES87115322T patent/ES2017982B3/es not_active Expired - Lifetime
- 1987-10-20 DE DE8787115322T patent/DE3764235D1/de not_active Expired - Lifetime
- 1987-10-20 AT AT87115322T patent/ATE55250T1/de not_active IP Right Cessation
- 1987-10-20 EP EP87115322A patent/EP0265812B1/de not_active Expired - Lifetime
- 1987-10-23 MX MX895887A patent/MX8958A/es unknown
- 1987-10-26 IN IN837/CAL/87A patent/IN168119B/en unknown
- 1987-10-27 FI FI874727A patent/FI87140C/fi not_active IP Right Cessation
- 1987-10-28 EG EG61687A patent/EG18333A/xx active
- 1987-10-29 PT PT86032A patent/PT86032B/pt unknown
- 1987-10-29 UA UA4203570A patent/UA11075A/uk unknown
- 1987-10-29 RU SU874203570A patent/RU1836079C/ru active
- 1987-10-29 IL IL84312A patent/IL84312A/xx not_active IP Right Cessation
- 1987-10-29 JP JP62272002A patent/JPS63159319A/ja active Granted
- 1987-10-30 ZA ZA878183A patent/ZA878183B/xx unknown
- 1987-10-30 AU AU80529/87A patent/AU598602B2/en not_active Ceased
- 1987-10-30 YU YU01973/87A patent/YU197387A/xx unknown
- 1987-10-30 DK DK569687A patent/DK169308B1/da not_active IP Right Cessation
- 1987-10-30 DD DD87308471A patent/DD262582A5/de not_active IP Right Cessation
- 1987-10-30 HU HU874900A patent/HU197987B/hu unknown
- 1987-10-30 KR KR1019870012077A patent/KR900003491B1/ko not_active Expired
- 1987-10-30 CA CA000550706A patent/CA1314231C/en not_active Expired - Lifetime
-
1990
- 1990-08-09 GR GR90400533T patent/GR3000708T3/el unknown
-
1992
- 1992-10-27 LV LVP-92-174A patent/LV10051B/lv unknown
-
1993
- 1993-07-07 GE GEAP1993972A patent/GEP19971025B/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES8706391A1 (es) | Un procedimiento para la preparacion de una composicion tensoactiva en polvo que fluye libremente. | |
| EP0290616A4 (en) | POLYVINYL ALCOHOL GEL GAMMA STERILIZATION PROCESS. | |
| IT8547834A0 (it) | Procedimento di trattamento di cellule con proteine ossee solubili per renderle idonee a stimolare la crescita di tessuti cartilaginei ed ossei,e prodotto ottenuto | |
| GEP19971025B (en) | Process for producing lyophilizate | |
| HUT51269A (en) | Process for producing benzimidazole derivatives and pharmaceutical compositions comprising same | |
| HUT46541A (en) | Process for production of new cimetidine medical preparatives | |
| PT80657A (en) | Process for preparing crystalline calcium pseudomonate or a hydrate thereof | |
| ZA915446B (en) | Growth hormone crystals and a process for production of these gh-crystals | |
| DE3571982D1 (en) | Benzisoselenazolethiones,process for their preparation and pharmaceutical products containing these compounds | |
| IE811513L (en) | Benzisoselenazolones | |
| DE3063858D1 (en) | Process for the production of a solid form containing a pharmaceutical active agent or a diagnostic | |
| DE3062352D1 (en) | Process for steeping corn, products so obtained and their use in the production of penicillin | |
| BG36042A3 (en) | Method for preparing a fermented dairy product containing viable bifidobacteria | |
| ES8200367A1 (es) | Procedimiento para la obtencion de riboflavina a partir de d-glucosa | |
| IT1117755B (it) | Procedimento per la sintesi enzimatica di un rna a doppio filamento prodotto ottenuto e composizione in duttrice di interferone che contiene detto prodotto | |
| FR2564106B1 (fr) | Vecteurs d'expression du facteur ix, cellules transformees par ces vecteurs et procede de preparation du facteur ix. | |
| HUT52958A (en) | Process for production of medical compositions assuring the constant release of the active substance | |
| EP0225770A3 (en) | Producing fibrous food products | |
| HUT50157A (en) | Process for production of 1,3-dioxane and medical compositions containing them as active substance | |
| GEP19960471B (en) | Method of producing n-sulfamine-3-(2-guanidinethiazol-4-ylmethylthio)-propioneamidine | |
| WO1990007260A3 (en) | 2,3-methanoproline | |
| ES8606898A1 (es) | Un procedimiento para producir un factor regulador de cancerendogeno humano | |
| ES8608315A1 (es) | Procedimiento para la obtencion de un somnifero conteniendo lorazepam | |
| BE883403A (fr) | Procede de preparation de 5-mercapto-1,2,3-triazoles et produits ainsi obtenus | |
| BG60236B2 (en) | Process for producing of cyclic propylene ester of dihydropyridine-s-phosphonic acid |